two new investigational drugs for type 2 diabetes, Januvia and Galvus

There's lots of buzz coming out of the latest American Diabetes Assoc meeting about two new investigational drugs for type 2 diabetes, Januvia and Galvus.

They're in a new class...DPP-4 inhibitors. They increase incretin. Watch for them later this fall and next year.

If you need info now, get our Detail-Document.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote